0001387131-19-001528.txt : 20190227
0001387131-19-001528.hdr.sgml : 20190227
20190227172904
ACCESSION NUMBER: 0001387131-19-001528
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190226
FILED AS OF DATE: 20190227
DATE AS OF CHANGE: 20190227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEDERMAN SETH
CENTRAL INDEX KEY: 0001563420
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36019
FILM NUMBER: 19639058
MAIL ADDRESS:
STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP
STREET 2: 509 MADISON AVE., SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp.
CENTRAL INDEX KEY: 0001430306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261434750
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 509 MADISON AVE. - SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 1-800-849-7894
MAIL ADDRESS:
STREET 1: 509 MADISON AVE. - SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC.
DATE OF NAME CHANGE: 20080320
4
1
ownership.xml
X0306
4
2019-02-26
0
0001430306
Tonix Pharmaceuticals Holding Corp.
TNXP
0001563420
LEDERMAN SETH
C/O TONIX PHARMACEUTICALS HOLDING CORP.
509 MADISON AVE., SUITE 306
NEW YORK
NY
10022
1
1
0
0
Chief Executive Officer
Stock Option
1.89
2019-02-26
4
A
0
23265
0.00
A
2020-02-26
2029-02-25
Common Stock
23265
23265
D
Stock Option
2.36
2019-02-26
4
A
0
23265
0.00
A
2020-02-26
2029-02-25
Common Stock
23265
23265
D
The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan.
/s/ Seth Lederman
2019-02-27